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Gastrointestinal tract infections in children are still a 
major problem in some developing countries, including 
Indonesia. The problem is primarily in establishing 
early diagnosis and providing rational therapy. 
Gastrointestinal infections caused by pathogenic 
bacteria must be adequately managed, since infections 
that cause loss of epithelial cell layer integrity, tissue 
damage, and inflammatory cell exudates are rapidly 
spreading resulting in systemic infection and sepsis, 
especially in younger children or infants.1,2
Fecal cultures are still the gold standard to 
determine pathogens as causes of infectious diarrhea 
in children, however it may take several days to get 
the results, therefore it is constrained to take early 
diagnosis and promptly provide rational therapy.3 On 
the other hand, stool culture facilities are not available 
in all health care facilities in Indonesia, so getting the 
germs that cause gastrointestinal infections becomes 
impossible, therefore not infrequently the therapy 
given to be empirical with ineffective results.
The World Health Organization (WHO) recommends 
the use of fecal leukocyte as a tool to determine the 
presence of Shigella infection as pathogen bacterial 
in children with bloody diarrhea. WHO stipulates 
the number of fecal leukocytes above 10/LPB as a 
marker of gastrointestinal infection by pathogenic 
bacteria, and in areas with no fecal culture facilities 
can provide antibiotics according to existing sensitivity 
data. Studies for other pathogenic bacteria as a cause 
of gastrointestinal infections are still very limited, 
so this opportunity becomes a challenge for clinical 
practitioners especially for those who work in areas 
with limited laboratory facilities.4
Uncontrolled use of antibiotics in recent years has 
caused the pattern of bacterial sensitivity to change, as 
well as the disease progression and clinical symptoms 
shown to be non-specific. In clinical practice, it is 
often seen that clinical symptoms are severe enough, 
although the markers of inflammation or mucosal 
damage are moderate. This condition provides 
important information for a further study whether 
pathogenic bacteria other than Shigella provide a 
pattern of mucosal damage or inflammation that is 
not the same, so antibiotic treatment need to be given 
earlier.
Limited study on bloody stools and stool leukocytes 
as an infectious diarrhea screening showed pathogenic 
bacterial infection in 70% of children with stool 
leukocytes >5/LPB. Another study shows the 
association of gastrointestinal infection by pathogenic 
bacteria with the numbers of stool leucocytes > 10/
LPB. The presence of blood in the stool is strongly 
associated with fecal leucocytes > 10/LPB.5,6
The study conducted by Nuraini et al showed the 
prevalent bacterial colitis infection in children with 
acute diarrhea of 6.82%, including strain EPEC of 
E.coli (16.67%), Salmonella sp (33.3%), C. Dificille 
(33.3% ) and Shigella sp (16.67%). The leucocyte 
cutting point < 8/LPB and > 8/LPB was the best value, 
with a sensitivity value of 0.833 and a specificity of 
0.549. Fecal leukocyte and fecal cultures examination 
showed an insignificant correlation in the diagnosis of 
bacterial infection colitis.7
The role of the number of fecal leukocytes and 
clinical appearance as a marker of gastrointestinal 
infection by pathogenic bacteria becomes a challenge 
for scientists to study, so that clinical practitioners in 
areas with limited laboratory support facilities can still 
provide health care based on scientific, rational, and 
cost effective evidence.
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